"Designing Growth Strategies is in our DNA"

Enzyme Replacement Therapy Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alglucosidasealfa, Agalsidase, Pancrelipase, Idursulfase, Laronidase, Imiglucerase, Elosulfasealfa, Asfotasealfa, Galsulfase, Velaglucerasealfa, and Others), By Route of Administration (Parenteral and Oral), By Indication (Type 1 Gaucher Disease, Pompe Disease, MPS (Mucopolysaccharidosis), Exocrine Pancreatic Insufficiency (EPI), Fabry Disease, Hypophosphatasia, and Others), By End-User (Hospitals and Homecare Settings & Infusion Centers), and Regional Forecast 2021-2028

Region : Global | Format: PDF | Report ID: FBI106424

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Speak to Analyst

Refresh Button
Booklet
  • Mar, 2022
  • 2020
  • 2017-2019
  • 150

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X